Sort
82,697 grants matching “vaccine development”
TASK X25: Preparedness for Testing NIAID Priority Vaccines in Neurovirulence and Reproductive Toxicology Studies
$784,072Randi Hornback · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2019 · AI
Exploring the membrane-related components of HIV-1 Env for immunogen design
$784,041Bing Chen · Boston Children'S Hospital · R01 · FY2024 · AI
Exploring the membrane-related components of HIV-1 Env for immunogen design
$784,041Bing Chen · Boston Children'S Hospital · R01 · FY2025 · AI
Rational development of a vaccine against tick-borne rickettsioses
$784,034Rong Megan Fang · University Of Texas Med Br Galveston · R01 · FY2024 · AI
Norovirus 3CL Protease-Based Anti-norovirus Therapeutics
$784,022Kyeong-Ok Chang · Kansas State University · R01 · FY2014 · AI
Southwest Clinical Trials Node: Clinical Research and Practice to Address Substance Use in Diverse, Rural, and Underserved Populations
$783,906Kimberly Page · University Of New Mexico Health Scis Ctr · UG1 · FY2025 · DA
HIV-1 Env protein structure and function assessed by parallel smFRET and cryoET
$783,886Walther H Mothes · Yale University · R37 · FY2024 · AI
Mechanisms of atherosclerotic cardiovascular complications
$783,846Chiara Giannarelli · New York University School Of Medicine · R01 · FY2025 · HL
Mechanisms of atherosclerotic cardiovascular complications in COVID19
$783,846Chiara Giannarelli · New York University School Of Medicine · R01 · FY2023 · HL
The effect of HIV exposure and infection on immunity to TB in children
$783,833Grace C John-Stewart · University Of Washington · R01 · FY2021 · AI
Intestinal microbiota-mediated rotavirus vaccine failure
$783,735Andrew T Gewirtz · Georgia State University · R01 · FY2023 · AI
Intestinal microbiota-mediated rotavirus vaccine failure
$783,735Andrew T Gewirtz · Georgia State University · R01 · FY2024 · AI
Intestinal microbiota-mediated rotavirus vaccine failure
$783,735Andrew T Gewirtz · Georgia State University · R01 · FY2025 · AI
Chemoenzymatic glycan editing for deciphering biological functions of glycans
$783,616Peng Wu · Scripps Research Institute, The · R35 · FY2021 · GM
Chemical Stabilization of shRNAs and their development as hepatitis C drugs
$783,579Brian H. Johnston · Somagenics, Inc. · R44 · FY2013 · AI
A vaccine for genital herpes that achieves sterilizing immunity
$783,564Harvey Michael Friedman · University Of Pennsylvania · R01 · FY2021 · AI
Characterizing the role of LDL related receptor 1 (Lrp1) as host entry factor for multiple bunyaviruses
$783,556Gaya K. Amarasinghe · Washington University · R01 · FY2023 · AI
Columbia University-Southern African AIDS International Training/Research Program
$783,551Quarraisha Abdool Karim · Columbia University Health Sciences · D43 · FY2014 · TW
Mechanisms of myocarditis and progressive cardiac fibrosis in chronic Trypanosoma cruzi infection.
$783,532Kathryn Marie Jones · Baylor College Of Medicine · R01 · FY2022 · AI
Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infection
$783,487Lishan Su · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AI
Rational development of a vaccine against tick-borne rickettsioses
$783,434Rong Megan Fang · University Of Texas Med Br Galveston · R01 · FY2023 · AI
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
$783,413John R. Chan · Rbhs-New Jersey Medical School · R01 · FY2022 · AI
SHIV-guided design of novel HIV-1 fusion peptide immunogens
$783,400George M Shaw · University Of Pennsylvania · R01 · FY2025 · AI
Native American Research Centers For Health (NARCH XII)
$783,375Daniel J. Calac · Indian Health Council, Inc. · S06 · FY2024 · GM
Systems Biology of Mumps Vaccine Response
$783,307Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2021 · AI